Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 1,371 |
| Receivables | 0 | 0 | 0 | 328 |
| Other current assets | 0 | 0 | 0 | 200 |
| TOTAL | $0 | $0 | $0 | $1,899 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 0 | 0 | 0 | 16,514 |
| TOTAL | $N/A | $N/A | $N/A | $16,514 |
| Total Assets | $0 | $0 | $0 | $18,413 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 310 |
| TOTAL | $0 | $0 | $0 | $310 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $0 | $310 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 0 | 8 |
| Retained earnings | 0 | 0 | 0 | -1,158 |
| Other shareholders' equity | 0 | 0 | 0 | 83 |
| TOTAL | $0 | $0 | $0 | $18,104 |
| Total Liabilities And Equity | $0 | $0 | $0 | $18,414 |